BE900241A - Procede de preparation d'ester de a-acetoxyethyle de cefuroxime. - Google Patents
Procede de preparation d'ester de a-acetoxyethyle de cefuroxime.Info
- Publication number
- BE900241A BE900241A BE0/213398A BE213398A BE900241A BE 900241 A BE900241 A BE 900241A BE 0/213398 A BE0/213398 A BE 0/213398A BE 213398 A BE213398 A BE 213398A BE 900241 A BE900241 A BE 900241A
- Authority
- BE
- Belgium
- Prior art keywords
- cefuroxime
- preparation
- acetoxyethyl ester
- cefuroxime axetil
- solvents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procédé pour l'obtention de céfuroxime axétil cristallin très pur. Le procédé consiste à faire cristalliser le céfuroxime axétil à partir d'une de ses solutions dans un solvant organique ou aqueux ou dans un mélange de ces deux types de solvants, puis à sècher et à isoler le produit. Les solvants préférés sont des acétates d'alkyle mélangés avec des éthers ou des hydrocarbures aliphatiques ou aromatiques.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838320521A GB8320521D0 (en) | 1983-07-29 | 1983-07-29 | Chemical process |
Publications (1)
Publication Number | Publication Date |
---|---|
BE900241A true BE900241A (fr) | 1985-01-28 |
Family
ID=10546505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/213398A BE900241A (fr) | 1983-07-29 | 1984-07-27 | Procede de preparation d'ester de a-acetoxyethyle de cefuroxime. |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPH0613526B2 (fr) |
KR (1) | KR910008377B1 (fr) |
AT (1) | AT392470B (fr) |
AU (2) | AU582121B2 (fr) |
BE (1) | BE900241A (fr) |
CA (1) | CA1265511A (fr) |
CH (1) | CH662121A5 (fr) |
DE (1) | DE3427828A1 (fr) |
DK (1) | DK165505C (fr) |
ES (1) | ES534695A0 (fr) |
FI (1) | FI76808C (fr) |
FR (1) | FR2549837B1 (fr) |
GB (2) | GB8320521D0 (fr) |
IE (1) | IE57726B1 (fr) |
IL (1) | IL72536A (fr) |
NL (1) | NL8402372A (fr) |
NO (1) | NO167292C (fr) |
NZ (1) | NZ209046A (fr) |
PT (1) | PT78985B (fr) |
SE (1) | SE463263B (fr) |
ZA (1) | ZA845830B (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8400024D0 (en) * | 1984-01-03 | 1984-02-08 | Glaxo Group Ltd | Cephalosporin antibiotics |
GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
US5063224A (en) * | 1990-07-09 | 1991-11-05 | Eli Lilly And Company | R-cefuroxime axetil |
IT1277426B1 (it) * | 1995-08-03 | 1997-11-10 | Acs Dobfar Spa | Forma cristallina biodisponibile del cefuroxima axetil |
CN1111537C (zh) * | 1997-05-15 | 2003-06-18 | 第一制糖株式会社 | 高纯晶形头孢呋辛1-乙酰氧乙酯的制备方法 |
KR100228264B1 (ko) * | 1997-08-02 | 1999-11-01 | 김선진 | 결정형 세푸록심 악세틸의 제조방법 |
CA2209868C (fr) * | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Compositions pharmaceutiques a base de cefuroxime axetil |
IN186539B (fr) * | 1997-09-29 | 2001-09-29 | Ranbaxy Lab Ltd | |
DE19907521A1 (de) * | 1998-02-20 | 1999-11-04 | Fako Ilaclari A S | Lösliches kristallines Cefuroxim axetil |
IN190849B (fr) | 2000-07-17 | 2003-08-23 | Ranbaxy Lab Ltd | |
AT411996B (de) | 2000-09-11 | 2004-08-26 | Sandoz Ag | Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes |
ITMI20011763A1 (it) * | 2001-08-10 | 2003-02-10 | Antibioticos Spa | Processo di preparazione di cefuroxime axelite ad elevata purezza |
ITMI20011925A1 (it) * | 2001-09-14 | 2003-03-14 | Antibioticos Spa | Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino |
TWI328006B (en) * | 2003-12-26 | 2010-08-01 | Nissan Chemical Ind Ltd | Crystal form of quinoline compound and process for its production |
CN100448879C (zh) * | 2004-07-22 | 2009-01-07 | 北京化工大学 | 一种无定型头孢呋辛酯的制备方法 |
DE102005019458A1 (de) | 2005-04-25 | 2006-10-26 | Grünenthal GmbH | Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1094545A (fr) * | 1976-02-16 | 1981-01-27 | Michael Gregson | Traduction non-disponible |
GB1571683A (en) * | 1976-02-16 | 1980-07-16 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
GB1598568A (en) * | 1977-04-19 | 1981-09-23 | Glaxo Lab Ltd | Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid |
JPS577485A (en) * | 1980-06-13 | 1982-01-14 | Takeda Chem Ind Ltd | Cephalosporin |
YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
GB8400024D0 (en) * | 1984-01-03 | 1984-02-08 | Glaxo Group Ltd | Cephalosporin antibiotics |
-
1983
- 1983-07-29 GB GB838320521A patent/GB8320521D0/en active Pending
-
1984
- 1984-07-27 ES ES534695A patent/ES534695A0/es active Granted
- 1984-07-27 DK DK366684A patent/DK165505C/da not_active IP Right Cessation
- 1984-07-27 BE BE0/213398A patent/BE900241A/fr not_active IP Right Cessation
- 1984-07-27 NL NL8402372A patent/NL8402372A/nl not_active Application Discontinuation
- 1984-07-27 GB GB08419202A patent/GB2145409B/en not_active Expired
- 1984-07-27 ZA ZA845830A patent/ZA845830B/xx unknown
- 1984-07-27 JP JP59155694A patent/JPH0613526B2/ja not_active Expired - Lifetime
- 1984-07-27 DE DE19843427828 patent/DE3427828A1/de not_active Ceased
- 1984-07-27 CA CA000459929A patent/CA1265511A/fr not_active Expired - Fee Related
- 1984-07-27 IE IE1938/84A patent/IE57726B1/en not_active IP Right Cessation
- 1984-07-27 AT AT2444/84A patent/AT392470B/de not_active IP Right Cessation
- 1984-07-27 CH CH3672/84A patent/CH662121A5/de not_active IP Right Cessation
- 1984-07-27 PT PT78985A patent/PT78985B/pt unknown
- 1984-07-27 KR KR1019840004465A patent/KR910008377B1/ko not_active IP Right Cessation
- 1984-07-27 FR FR8412011A patent/FR2549837B1/fr not_active Expired
- 1984-07-27 AU AU31256/84A patent/AU582121B2/en not_active Ceased
- 1984-07-27 NO NO843055A patent/NO167292C/no not_active IP Right Cessation
- 1984-07-27 FI FI843011A patent/FI76808C/fi not_active IP Right Cessation
- 1984-07-27 SE SE8403897A patent/SE463263B/sv not_active IP Right Cessation
- 1984-07-29 IL IL72536A patent/IL72536A/xx not_active IP Right Cessation
- 1984-07-30 NZ NZ209046A patent/NZ209046A/en unknown
-
1989
- 1989-06-16 AU AU36601/89A patent/AU634965B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE900241A (fr) | Procede de preparation d'ester de a-acetoxyethyle de cefuroxime. | |
FR2557124B1 (fr) | Procede continu pour la fabrication de dispersions de pigments de phtalocyanines dans un solvant organique | |
BE855235A (fr) | Procede continu de preparation d'isocyanates organiques | |
PT71209A (fr) | Procede pour la preparation de nouveaux composes organiques | |
JPS56138181A (en) | Ml-236a and mb-530a derivative | |
EP0039126A3 (fr) | Compositions aqueuses à base de polymères aliphatiques chlorés et leur préparation et utilisation | |
DE2964324D1 (en) | Process for the preparation of compounds containing hydantoin groups | |
FR2657539B1 (fr) | Procede d'extraction des constituants d'une matiere vegetale utilisant des solvants selectifs. | |
JPS5242864A (en) | Process for preparation of 1x, 24-dihydroxycholecalciferol | |
FR2276270A1 (fr) | Procede d'elimination de composes organiques chlores de liquides aqueux | |
KR840002241A (ko) | 센나 약제로부터 완화제를 제조하는 공정 | |
FR2410660A1 (fr) | Derives de 16,17-pyrazolino- et 16,17-isopyrazolino-1,4-pregnadiene utilisables comme medicaments et procede pour les preparer | |
GB2011800A (en) | A Process for Producing Granules from a Solution | |
RU1838311C (ru) | Способ получени 2-(3-пиридил)тетрагидротиапиранкарботиоамид-2-оксида-1(1R, 2R) | |
JPS55151536A (en) | New optically active tert-leucine d-10-camphasulfonic acid salt and its preparation | |
KR880701272A (ko) | r-1-시아노-1-R²-시스-4-R¹-시클로헥산 화합물 | |
JPS5731630A (en) | Preparation of bisphenolethane | |
JPS5610172A (en) | 1-thiocarbamoyl-2-imidazolidinone compound | |
ES475512A1 (es) | Procedimiento para la obtencion de 21- esteres de corticos- teroides a partir de 21- alquilsulfonatos | |
JPS5268155A (en) | Preparation of 4'-alkyl-4-biphenylcarbonitrile | |
JPS51122043A (en) | Process for preparation of 3-hydroxy-5- cycloxycyclopento-1-ene deriva tives | |
JPS52122398A (en) | Preparation of 02 , 3'-cyclopyrimidinenucleosides | |
JPS57197279A (en) | Novel hexaminum compound and its preparation | |
JPS52153937A (en) | Preparation of novel phenylalanine derivatives | |
JPS52115797A (en) | Production of liquid state substance containing titanium trichloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: *GLAXO GROUP LTD Effective date: 20020731 |